Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice

Clinical and Experimental Allergy

Volumn 34, Issue 3, 2004, Pages 488-496

  Barends, M ^a,b   De Rond, L G H ^a   Dormans, J ^a   Van Oosten, M ^a   Boelen, A ^a   Neijens, H J ^b   Osterhaus, A D M E ^b   Kimman, T G ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Allergy; Eosinophils; Influenza A; Mice; PVM; RSV; Th2 cytokines

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; OVALBUMIN;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; INFLUENZA VIRUS A; LUNG BLOOD VESSEL; LUNG PARENCHYMA; MOUSE; MOUSE STRAIN; NONHUMAN; ORTHOMYXOVIRUS; PNEUMONIA; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT ALLERGY; SENSITIZATION; SERUM; TH2 CELL;

ANIMALS; FEMALE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFLUENZA A VIRUS; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; MICE; MICE, INBRED BALB C; MURINE PNEUMONIA VIRUS; ORTHOMYXOVIRIDAE INFECTIONS; OVALBUMIN; PNEUMOVIRUS INFECTIONS; PULMONARY EOSINOPHILIA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RNA, MESSENGER; VIRUS DISEASES;

EID: 1642383747     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.01906.x     Document Type: Article

References (38)

1. World Health Organization. Bronchial Asthma. WHO fact Sheet No 206; January 2000. http://www.who.int/inf-fs/en/fact206.html.
2. Savelkoul HF, Neijens HJ. Immune responses during allergic sensitization and the development of atopy. Allergy 2000; 55:989-97.
3. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001; 344:350-62.
4. Murray M, Webb MS, O'Callaghan C, Swarbrick AS, Milner AD. Respiratory status and allergy after bronchiolitis. Arch Dis Child 1992; 67:482-7.
5. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161:1501-7.
6. Collins PL, Chanock RM, Murphy BR. Respiratory Syncytial Virus. In: Fields BN et al. eds. Fields virology. Philadelphia: Lippincott-Raven Publishers, 2001; 1443-85.
7. Barends M, Boelen A, de Rond L et al. Influence of respiratory syncytial virus infection on cytokine and inflammatory responses in allergic mice. Clin Exp Allergy 2002; 32:463-71.
8. Peebles RS Jr, Sheller JR, Johnson JE, Mitchell DB, Graham BS. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice. J Med Virol 1999; 57:186-92.
9. Barends M, Boelen A, de Rond L et al. Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-gamma. J Med Virol 2003; 69:156-62.
10. van den Hoogen BG, de Jong JC, Groen J et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nature Med 2001; 7:719-24.
11. Chambers P, Pringle CR, Easton AJ. Molecular cloning of pneumonia virus of mice. J Virol 1990; 64:1869-72.
12. Ling R, Pringle CR. Polypeptides of pneumonia virus of mice. I. Immunological cross-reaction and post-translational modifications. J Gen Virol 1989; 70:1427-40.
13. Murphy BR, Webster RG. Orthomyxoviruses. In: Fields BN et al. eds. Field virology. Philadelphia: Lippincott-Raven Publishers, 1996; 1397-445.
14. Suzuki S, Suzuki Y, Yamamoto N, Matsumoto Y, Shirai A, Okubo T. Influenza A virus infection increases IgE production and airway responsiveness in aerosolized antigen-exposed mice. J Allergy Clin Immunol 1998; 102:732-40.
15. O'Donnell DR, Openshaw PJ. Anaphylactic sensitization to aeroantigen during respiratory virus infection. Clin Exp Allergy 1998; 28:1501-8.
16. Teichtahl H, Buckmaster N, Pertnikovs E. The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest 1997; 112:591-6.
17. Eriksson M, Bennet R, Nilsson A. Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy. Pediatr Allergy Immunol 2000; 11:193-7.
18. Boelen A, Kwakkel J, Barends M, de Rond L, Dormans J, Kimman T. Effect of lack of Interleukin-4, Interleukin-12, Interleukin-18, or the Interferon-gamma receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice. J Med Virol 2002; 66:552-60.
19. Su Y-H, Yan X-T, Oakes JE, Lausch RN. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection. J Virol 1996; 70:1277-81.
20. Domachowske JB, Bonville CA, Easton AJ, Rosenberg HF. Gene expression in epithelial cells in response to pneumovirus infection. J Leukoc Biol 2002; 71:966-72.
21. Byrd LG, Prince GA. Animal models of respiratory syncytial virus infection. Clin Infect Dis 1997; 25:1363-8.
22. Domachowske JB, Bonville CA, Rosenberg HF. Gene expression in epithelial cells in response to pneumovirus infection. Respir Res 2001; 2:225-33.
23. Cook PM, Eglin RP, Easton AJ. Pathogenesis of pneumovirus infections in mice: detection of pneumonia virus of mice and human respiratory syncytial virus mRNA in lungs of infected mice by in situ hybridization. J Gen Virol 1998; 79:2411-7.
24. Bonville CA, Easton AJ, Rosenberg HF, Domachowske JB. Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J Virol 2003; 77:1237-44.
25. Lamb RA, Krug RM. Orthomyxoviridae: the viruses and their replication. In: Fields BN, ed. Fields virology. Philadelphia: Lippincott-Raven Publisher, 1996; 1353-95.
26. Graham BS, Johnson TR, Peebles RS. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 2000; 48:237-47.
27. Srikiatkhachorn A, Braciale TJ. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection. J Virol 1997; 71:678-85.
28. Hancock GE, Speelman DJ, Heers K, Bortell E, Smith J, Cosco C. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J Virol 1996; 70:7783-91.
29. Johnson TR, Fischer JE, Graham BS. Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine. J Gen Virol 2001; 82:2107-16.
30. Yilma T, Zee YC, Osebold JW. Immunofluorescence determination of the pathogenesis of infection with influenza virus in mice following exposure to aerosolized virus. J Infect Dis 1979; 139:458-64.
31. Miller RR. Viral infections of the respiratory tract. In: Thurlbeck WM, ed. Pathology of the lung. New York: Thieme medical publishers, 1988; 147-79.
32. Yamamoto N, Suzuki S, Suzuki Y et al. Immune response induced by airway sensitization after influenza A virus infection depends on timing of antigen exposure in mice. J Virol 2001; 75:499-505.
33. Tsitoura DC, Kim S, Dabbagh K, Berry G, Lewis DB, Umetsu DT. Respiratory infection with influenza A virus interferes with the induction of tolerance to aeroallergens. J Immunol 2000; 165:3484-91.
34. Freihorst J, Piedra PA, Okamoto Y, Ogra PL. Effect of respiratory syncytial virus infection on the uptake of and immune response to other inhaled antigens. Proc Soc Exp Biol Med 1988; 188:191-7.
35. Welliver RC. Immunology of respiratory syncytial virus in infection: eosinophils, cytokines, chemokines and asthma. Pediatr Infect Dis J 2000; 19:780-3.
36. Wang S, Halsworth PG, Dowling KD, Alpers JH, Bowden JJ, Forsyth KD. Adhesion molecule expression on epithelial cells infected with respiratory syncytial virus. Eur Respir J 2000: 358-66.
37. Wijburg OLC, Dinatale S, Vadolas J, van Rooijen N, Strugnell RA. Alveolar macrophages regulate the induction of primary cytotoxic T-lymphocyte responses during influenza virus infection. J Virol 1997; 71:9450-7.
38. Proust B, Nahori MA, Ruffle C, Lefort J, Vargaftig BB. Persistence of bronchopulmonary hyper-reactivity and eosinophilic lung inflammation after anti-IL-5 or -IL-13 treatment in allergic BALB/c and IL-4Ralpha knockout mice. Clin Exp Allergy 2003; 33:119-31.